When it comes to the brain, not all proteins are created equal. Some proteins are downright troublemakers, especially when they gather in blood vessels.
Enter Cerebral Amyloid Angiopathy (CAA). This condition is defined by the buildup of amyloid proteins in the brain’s blood vessels. And guess what? It’s not just a nuisance; it quadruples the risk of developing dementia within five years. Yes, four times higher. That’s a staggering jump from 10% to 42%.
CAA doesn’t care if you’ve had a stroke or not. Its ominous shadow looms large, regardless of stroke history. Nearly 2 million Medicare adults aged 65 and older have been examined from 2016 to 2022. The findings? They’re not pretty. CAA triggers non-stroke mechanisms that elevate dementia incidence. Basically, it’s like being handed a loaded gun with dementia as the bullet.
CAA casts a wide net, increasing dementia risk regardless of stroke history—it’s a silent threat lurking in our blood vessels.
Now, if you think having a stroke makes things worse, you’d be right. CAA with a stroke raises dementia chances a whopping 4.5 times. It turns out that the protein plaques that accumulate around blood vessels are not just bad for your arteries; they’re also playing a nasty game with your brain health. Even without a stroke, the risk remains alarmingly high.
In a study of 1.9 million adults, researchers tracked shifts between different health states. They looked at how long individuals spent in various conditions, measuring the onset of dementia. Stroke types, whether ischemic or hemorrhagic, were all considered, but the takeaway was clear: CAA is a risk factor that often goes unnoticed. Proactive screening for cognitive changes post-CAA diagnosis is crucial to prevent further decline.
And while we’re at it, let’s throw in some genetics. The FMNL2 gene is linked to both cerebrovascular risks and Alzheimer’s. High levels of this protein are found in Alzheimer’s patients, reshaping the blood-brain barrier, which is just perfect, right? FMNL2 gene may help explain the connection between cerebrovascular risk factors and Alzheimer’s.
With vascular risks like high blood pressure and cholesterol, the brain’s blood vessels are under siege.
In short, CAA and its protein pals are making a mess of things. It’s a wake-up call, and it’s time to pay attention.
